サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300854

内分泌治療薬の世界市場規模調査＆予測：治療領域別（糖尿病治療薬、HGH、甲状腺ホルモン障害、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別分析、2023-2030年

Global Endocrinology Drugs Market Size study & Forecast, by Therapy Area (Diabetes drugs, HGH, Thyroid hormone disorders, Others), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
内分泌治療薬の世界市場規模調査＆予測：治療領域別（糖尿病治療薬、HGH、甲状腺ホルモン障害、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別分析、2023-2030年
出版日: 2023年06月19日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の内分泌治療薬市場は、2022年に約250億8,424万米ドルと評価され、予測期間2023-2030年には7.82%以上の健全な成長率で成長すると予測されています。

内分泌治療薬は、内分泌系のホルモンバランスの乱れや機能不全に関連する内分泌疾患を扱う。内分泌治療薬は、内分泌疾患を患う患者に治療オプションを提供する上で重要な役割を果たしています。内分泌治療薬市場は、内分泌治療薬の臨床試験の増加や、糖尿病や甲状腺などの内分泌疾患の増加といった要因によって牽引されています。

糖尿病の治療に使用される内分泌治療薬には、血糖値の調節を助けるホルモンであるインスリンや、メトホルミン、スルホニル尿素、メグリチニドなどの経口血糖降下薬（OHA）があります。これらの薬剤は血糖値を下げ、糖尿病に伴う合併症を予防するためのものです。世界保健機関（WHO）によると、2021年には5億3,700万人が糖尿病と診断され、2045年には7億8,300万人まで増加すると予測されています。このように、内分泌疾患の増加は市場の成長を促進します。さらに、先進的な医薬品開発と高齢化人口の増加が市場成長の好機を生み出しています。しかし、主要な内分泌治療薬の特許失効は、2023-2030年の予測期間中に内分泌治療薬市場の成長を阻害する主要な課題です。

内分泌治療薬の世界市場調査において考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、高いヘルスケア費用と国民の高い意識により、2022年の市場を独占し、米国は総GDPの約17.8%をヘルスケアに費やしています。アジア太平洋地域は、疾病の蔓延、医療費の増加、人口の急増、政府の取り組みなどの要因により、大きな成長が見込まれています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 内分泌治療薬市場：地域別、2020-2030年
    • 内分泌治療薬市場：治療領域別、2020-2030年
    • 内分泌治療薬市場：流通チャネル別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提

第2章 内分泌治療薬の世界市場定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 内分泌治療薬の世界市場力学

  • 内分泌治療薬市場のインパクト分析（2020-2030年）
    • 市場促進要因
      • 内分泌治療薬開発のための臨床試験の増加
      • 内分泌疾患の有病率の増加
    • 市場の課題
      • 特許切れ
    • 市場機会
      • 医薬品開発活動の進展
      • 高齢化人口の増加

第4章 内分泌治療薬の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 内分泌治療薬の世界市場：治療領域別

  • 市場スナップショット
  • 内分泌治療薬の世界市場：治療領域別、実績-潜在能力分析
  • 内分泌治療薬の世界市場：治療領域別、推定・予測2020-2030年
  • 内分泌治療薬市場、サブセグメント分析
    • 糖尿病治療薬
    • HGH
    • 甲状腺ホルモン障害
    • その他

第6章 内分泌治療薬の世界市場：流通チャネル別

  • 市場スナップショット
  • 内分泌治療薬の世界市場：流通チャネル別、実績-潜在能力分析
  • 内分泌治療薬の世界市場：流通チャネル別、推定・予測2020～2030年
  • 内分泌治療薬市場、サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第7章 内分泌治療薬の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 内分泌治療薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 治療領域の推定・予測、2020-2030年
      • 流通チャネルチャネル別の推定・予測、2020-2030年
    • カナダ
  • 欧州内分泌治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋内分泌治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ内分泌医薬品市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Abbott Laboratories
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Acerus Pharmaceuticals corp.
    • Hanmi Pharm co. Ltd
    • Oramed Pharmaceuticals
    • Pfizer Inc.
    • F. Hoffmann La Roche Ltd.
    • Glaosmithkline Plc
    • Biocon Ltd.
    • Ascendis Pharma AS
    • Endo Inernational Plc

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提
図表

LIST OF TABLES

  • TABLE 1. Global Endocrinology Drugs Market, report scope
  • TABLE 2. Global Endocrinology Drugs Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Endocrinology Drugs Market estimates & forecasts by Therapy Area 2020-2030 (USD Million)
  • TABLE 4. Global Endocrinology Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Million)
  • TABLE 5. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 6. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. U.S. Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 17. U.S. Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. Canada Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 19. Canada Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 20. Canada Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. UK Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 22. UK Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 23. UK Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. Germany Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 25. Germany Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 26. Germany Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. France Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 28. France Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 29. France Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. Italy Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 31. Italy Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 32. Italy Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Spain Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 34. Spain Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 35. Spain Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. RoE Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 37. RoE Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 38. RoE Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. China Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 40. China Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 41. China Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. India Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 43. India Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 44. India Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. Japan Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 46. Japan Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 47. Japan Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. South Korea Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 49. South Korea Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 50. South Korea Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. Australia Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 52. Australia Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 53. Australia Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. RoAPAC Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. Brazil Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 58. Brazil Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 59. Brazil Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Mexico Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 61. Mexico Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 62. Mexico Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. RoLA Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 64. RoLA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 65. RoLA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. Saudi Arabia Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 67. South Africa Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 68. RoMEA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Endocrinology Drugs Market
  • TABLE 70. List of primary sources, used in the study of global Endocrinology Drugs Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Endocrinology Drugs Market, research methodology
  • FIG 2. Global Endocrinology Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Endocrinology Drugs Market, key trends 2022
  • FIG 5. Global Endocrinology Drugs Market, growth prospects 2023-2030
  • FIG 6. Global Endocrinology Drugs Market, porters 5 force model
  • FIG 7. Global Endocrinology Drugs Market, pest analysis
  • FIG 8. Global Endocrinology Drugs Market, value chain analysis
  • FIG 9. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Endocrinology Drugs Market, regional snapshot 2020 & 2030
  • FIG 15. North America Endocrinology Drugs Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Endocrinology Drugs Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Endocrinology Drugs Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Endocrinology Drugs Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Endocrinology Drugs Market 2020 & 2030 (USD Million)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Endocrinology Drugs Market is valued at approximately USD 25084.24 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.82% over the forecast period 2023-2030. Endocrinology drugs deals with endocrine disorders, which are related to hormone imbalance and dysfunction in the endocrine system. Endocrinology drugs play an important role in providing therapeutic options for patients suffering from the endocrine disorder. The endocrinology drug market is being driven by factors such as Growing clinical trials of endocrinology drugs and rising endocrine disorders such as diabetes and thyroid.

Endocrinology drugs used to treat diabetes include insulin, which is a hormone that helps regulate blood sugar levels, and oral hypoglycemic agents (OHAs) such as metformin, sulfonylureas, and meglitinides. These drugs are designed to lower blood sugar levels and prevent complications associated with diabetes. According to the World health organization 537 million people lining with diabetes in 2021 and projections show this number is rising to 783 million people diabetic by 2045. Thus, rising in endocrine disorders fuels the market growth. In addition, advanced drug development and a growing aging population are creating a lucrative opportunity for market growth. However, Patent expiry on major endocrinology drugs is the major challenge impeding the endocrinology drugs market growth during the forecast years 2023-2030.

The key regions considered for the Global Endocrinology Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to high healthcare expenses and a high level of awareness in public, USA spends around 17.8% of the total GDP on healthcare. Where Asia Pacific is expected to have significant growth owing to factors such as rising disease prevalence, rising healthcare expenditure, a rapidly growing population and Government initiatives.

Major market players included in this report are:

  • Abbott Laboratories
  • Acerus Pharmaceuticals Corp.
  • Hanmi Pharm Co. Ltd.
  • Oramed Pharmaceuticals Inc.
  • Pfizer Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Biocon Ltd.
  • Ascendis Pharma AS
  • Endo International Plc

Recent Developments in the Market:

  • On February 2022, Biocon announced the acquisition of Viatris' biosimilar portfolio for USD 3.335 billion. This acquisition strengthened Biocon's biosimilar product portfolio and improved its revenue generation.
  • In Aug 2021, The U.S. Food and Drug Administration (FDA) approved an expanded label for Eli Lilly and Company's rapid-acting Endocrinology Drugs, Lyumjev® (Endocrinology Drugs lispro-AABC injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2 diabetes, to include administration via continuous subcutaneous Endocrinology Drugs infusion (CSII) with an Endocrinology Drugs pump.
  • In July 2021, Semglee, a first-of-its-kind Endocrinology Drugs product made by India's Biocon, gets United States approval. Semglee, manufactured by Biocon Biologics, a Bengaluru-based pharmaceutical company, is both interchangeable with and biosimilar to Lantus, a long-acting Endocrinology Drugs product already approved in the United States.

Global Endocrinology Drugs Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Therapy Area, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy Area:

  • Diabetes drugs
  • HGH
  • Thyroid hormone disorders
  • Others

By Distribution Channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Endocrinology Drugs Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Endocrinology Drugs Market, by Therapy Area, 2020-2030 (USD Million)
    • 1.2.3. Endocrinology Drugs Market, by Distribution Channel , 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Endocrinology Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Endocrinology Drugs Market Dynamics

  • 3.1. Endocrinology Drugs Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing clinical trials for development of endocrinology drugs
      • 3.1.1.2. Growing prevalence of endocrine disorder
    • 3.1.2. Market Challenges
      • 3.1.2.1. Expiry of patents
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancement in drug development activities
      • 3.1.3.2. Growing aging population

Chapter 4. Global Endocrinology Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Endocrinology Drugs Market, by Therapy Area

  • 5.1. Market Snapshot
  • 5.2. Global Endocrinology Drugs Market by Therapy Area, Performance - Potential Analysis
  • 5.3. Global Endocrinology Drugs Market Estimates & Forecasts by Therapy Area 2020-2030 (USD Million)
  • 5.4. Endocrinology Drugs Market, Sub Segment Analysis
    • 5.4.1. Diabetes drug
    • 5.4.2. HGH
    • 5.4.3. Thyroid hormone disorder
    • 5.4.4. Other

Chapter 6. Global Endocrinology Drugs Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Endocrinology Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Endocrinology Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
  • 6.4. Endocrinology Drugs Market, Sub Segment Analysis
    • 6.4.1. Hospital pharmacies
    • 6.4.2. Retail pharmacies
    • 6.4.3. Online pharmacies

Chapter 7. Global Endocrinology Drugs Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Endocrinology Drugs Market, Regional Market Snapshot
  • 7.4. North America Endocrinology Drugs Market
    • 7.4.1. U.S. Endocrinology Drugs Market
      • 7.4.1.1. Therapy Area breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Distribution ChannelChannel breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Endocrinology Drugs Market
  • 7.5. Europe Endocrinology Drugs Market Snapshot
    • 7.5.1. U.K. Endocrinology Drugs Market
    • 7.5.2. Germany Endocrinology Drugs Market
    • 7.5.3. France Endocrinology Drugs Market
    • 7.5.4. Spain Endocrinology Drugs Market
    • 7.5.5. Italy Endocrinology Drugs Market
    • 7.5.6. Rest of Europe Endocrinology Drugs Market
  • 7.6. Asia-Pacific Endocrinology Drugs Market Snapshot
    • 7.6.1. China Endocrinology Drugs Market
    • 7.6.2. India Endocrinology Drugs Market
    • 7.6.3. Japan Endocrinology Drugs Market
    • 7.6.4. Australia Endocrinology Drugs Market
    • 7.6.5. South Korea Endocrinology Drugs Market
    • 7.6.6. Rest of Asia Pacific Endocrinology Drugs Market
  • 7.7. Latin America Endocrinology Drugs Market Snapshot
    • 7.7.1. Brazil Endocrinology Drugs Market
    • 7.7.2. Mexico Endocrinology Drugs Market
  • 7.8. Middle East & Africa Endocrinology Drugs Market
    • 7.8.1. Saudi Arabia Endocrinology Drugs Market
    • 7.8.2. South Africa Endocrinology Drugs Market
    • 7.8.3. Rest of Middle East & Africa Endocrinology Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Acerus Pharmaceuticals corp.
    • 8.3.3. Hanmi Pharm co. Ltd
    • 8.3.4. Oramed Pharmaceuticals
    • 8.3.5. Pfizer Inc.
    • 8.3.6. F. Hoffmann La Roche Ltd.
    • 8.3.7. Glaosmithkline Plc
    • 8.3.8. Biocon Ltd.
    • 8.3.9. Ascendis Pharma AS
    • 8.3.10. Endo Inernational Plc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption